User talk:GIP_Genoveva

Threads on this page older than 120 days and marked resolved have been moved to an archive subpage. Unresolved threads were left in place regardless of age. This is an automated message. — ArchiveBot (talk) 11:22, 7 December 2024 (UTC)

★ For sustained, careful work on Hunan Aslsen Technology and the articles around it — particularly for checking figures against their sources rather than against other articles, which is the slower and correct way round. Thank you. — GroupBuyGalen (talk) 18:26, 9 August 2025 (UTC)

Much appreciated. It is a slow way to work but it is the only way I trust. — GIP_Genoveva (talk) 12:46, 10 August 2025 (UTC)

The categories on Shanghai ERP Biotechnology and Glucagon-like peptide-1 disagree about where the topic sits. Both are defensible; having both is not, because the two articles then never appear in the same listing. Could you take a view on the talk page of whichever you know better? — COA_Colwyn (talk) 21:04, 30 September 2025 (UTC)

Thank you. I had been adding the leaf category without the parent, which explains why the portal listings looked so thin. — GIP_Genoveva (talk) 11:09, 2 October 2025 (UTC)

Welcome to PeptidePedia Wiki. Two things worth reading early: Project:Verifiability, which is stricter here than on most wikis because of the subject matter, and Project:Manual of style, which settles the unit and spelling conventions so that articles can be read comparatively.

If a claim is worth making it is worth citing, and if a number is worth giving it is worth giving with its units and its source. Ask anything on the talk page of the article in question — that is where the reference-desk traffic goes. — SatietySunniva (talk) 19:28, 12 January 2026 (UTC)